Bart O. Roep

23.6k total citations · 3 hit papers
305 papers, 16.2k citations indexed

About

Bart O. Roep is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, Bart O. Roep has authored 305 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 242 papers in Genetics, 168 papers in Surgery and 138 papers in Immunology. Recurrent topics in Bart O. Roep's work include Diabetes and associated disorders (239 papers), Pancreatic function and diabetes (164 papers) and Diabetes Management and Research (118 papers). Bart O. Roep is often cited by papers focused on Diabetes and associated disorders (239 papers), Pancreatic function and diabetes (164 papers) and Diabetes Management and Research (118 papers). Bart O. Roep collaborates with scholars based in Netherlands, United States and United Kingdom. Bart O. Roep's co-authors include Mark Peakman, Timothy Tree, Gaby Duinkerken, Arnaud Zaldumbide, Mark A. Atkinson, Colin Dayan, Arno R. van der Slik, Jan W. Drijfhout, Tatjana Nikolić and Amanda J. Bishop and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Bart O. Roep

304 papers receiving 15.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

2005 676 citations Colin Dayan, Amanda J. Bishop et al. Diabetes profile →
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

2012 509 citations Ken Coppieters, Francesco Dotta et al. The Journal of Experimental Medicine profile →
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

2020 396 citations Bart O. Roep, Arnaud Zaldumbide et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bart O. Roep Netherlands	67	9.8k	7.3k	6.4k	5.7k	2.0k	305	16.2k
Mark Peakman United Kingdom	60	5.6k 0.6×	3.8k 0.5×	5.4k 0.8×	3.2k 0.5×	1.5k 0.7×	244	11.4k
Lucienne Chatenoud France	59	4.4k 0.4×	3.1k 0.4×	5.9k 0.9×	2.0k 0.4×	1.3k 0.7×	272	11.4k
Thomas W. H. Kay Australia	55	4.5k 0.5×	4.0k 0.5×	3.9k 0.6×	2.4k 0.4×	2.1k 1.1×	200	10.4k
Lorenzo Piemonti Italy	60	3.1k 0.3×	4.7k 0.6×	3.9k 0.6×	2.5k 0.4×	3.4k 1.7×	290	13.5k
Grant Morahan Australia	46	3.6k 0.4×	2.4k 0.3×	3.0k 0.5×	1.6k 0.3×	2.0k 1.0×	198	8.1k
Olle Korsgren Sweden	62	6.0k 0.6×	10.3k 1.4×	1.8k 0.3×	4.1k 0.7×	2.6k 1.3×	390	13.6k
Jane H. Buckner United States	55	2.8k 0.3×	1.4k 0.2×	7.2k 1.1×	1.0k 0.2×	2.0k 1.0×	188	11.8k
Conny Gysemans Belgium	49	2.3k 0.2×	1.8k 0.2×	3.8k 0.6×	1.2k 0.2×	2.4k 1.2×	144	10.8k
Hiroshi Nagura Japan	51	1.3k 0.1×	1.7k 0.2×	1.7k 0.3×	1.1k 0.2×	2.2k 1.1×	245	8.7k
Roland Jonsson Norway	65	2.1k 0.2×	2.3k 0.3×	4.1k 0.6×	591 0.1×	2.2k 1.1×	314	13.0k

Countries citing papers authored by Bart O. Roep

Since Specialization

Citations

This map shows the geographic impact of Bart O. Roep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart O. Roep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart O. Roep more than expected).

Fields of papers citing papers by Bart O. Roep

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart O. Roep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart O. Roep. The network helps show where Bart O. Roep may publish in the future.

Co-authorship network of co-authors of Bart O. Roep

This figure shows the co-authorship network connecting the top 25 collaborators of Bart O. Roep. A scholar is included among the top collaborators of Bart O. Roep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart O. Roep. Bart O. Roep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McDonald, Timothy J., Richard A. Oram, Pleun de Groen, et al.. (2023). Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes. Diabetes Care. 47(7). 1114–1121. 14 indexed citations

Shuck, Sarah C., Peter Achenbach, Bart O. Roep, et al.. (2023). Methylglyoxal products in pre-symptomatic type 1 diabetes. Frontiers in Endocrinology. 14. 1108910–1108910. 5 indexed citations

McDonald, Timothy J., Elena Rampanelli, Pleun de Groen, et al.. (2023). 27-OR: Residual Beta-Cell Function Associates with Lower Glycaemic Variability and More Time in Range in Individuals with Type 1 Diabetes. Diabetes. 72(Supplement_1). 1 indexed citations

Halteren, Astrid G. S. van, Sandra Laban, Roula Tsonaka, et al.. (2022). A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease. Blood. 141(11). 1277–1292. 2 indexed citations

Hilbrands, Robert, Ursule Van de Velde, Geert Stangé, et al.. (2021). Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients. American Journal of Transplantation. 22(3). 927–936. 9 indexed citations

Bayless, Nicholas, Jeffrey A. Bluestone, Samantha Bucktrout, et al.. (2021). Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR. Journal for ImmunoTherapy of Cancer. 9(9). e002627–e002627. 19 indexed citations

Keymeulen, Bart, André van Maurik, David R. Inman, et al.. (2020). A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes. Diabetologia. 64(2). 313–324. 38 indexed citations

Hammersley, S., Timothy J. McDonald, Beverley M. Shields, et al.. (2019). Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA_1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?. Diabetic Medicine. 36(9). 1092–1099. 27 indexed citations

Shields, Beverley M., Timothy J. McDonald, Richard A. Oram, et al.. (2018). C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase. Diabetes Care. 41(7). 1486–1492. 75 indexed citations

10.

Roep, Bart O., Nanette Solvason, Peter A. Gottlieb, et al.. (2013). Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8 ⁺ T Cells in Type 1 Diabetes. Science Translational Medicine. 5(191). 191ra82–191ra82. 127 indexed citations

11.

Stuart, A. A. Verrijn, et al.. (2012). CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clinical & Experimental Immunology. 170(1). 57–65. 37 indexed citations

12.

Coppieters, Ken, Francesco Dotta, Natalie Amirian, et al.. (2012). Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine. 209(1). 51–60. 509 indexed citations breakdown →

13.

Zaldumbide, Arnaud, Françoise Carlotti, Manuel A.F.V. Gonçalves, et al.. (2012). Adenoviral Vectors Stimulate Glucagon Transcription in Human Mesenchymal Stem Cells Expressing Pancreatic Transcription Factors. PLoS ONE. 7(10). e48093–e48093. 11 indexed citations

14.

Titulaer, Maarten J., Paul Maddison, Jacob K. Sont, et al.. (2011). Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS. Journal of Clinical Oncology. 29(7). 902–908. 117 indexed citations

15.

Chamorro, Sonia, Juan J. García‐Vallejo, Wendy W. J. Unger, et al.. (2009). TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program. The Journal of Immunology. 183(5). 2984–2994. 81 indexed citations

16.

Dotta, Francesco, Stefano Censini, Astrid G. S. van Halteren, et al.. (2007). Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proceedings of the National Academy of Sciences. 104(12). 5115–5120. 419 indexed citations

17.

Arif, Sefina, Timothy Tree, Jennifer Tremble, et al.. (2004). Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. Journal of Clinical Investigation. 113(3). 451–463. 401 indexed citations

18.

Halteren, Astrid G. S. van, Marrie J. Kardol, Arend Mulder, & Bart O. Roep. (2004). Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia. 48(1). 75–82. 32 indexed citations

19.

Halteren, Astrid G. S. van, Bart O. Roep, Willem van Eden, et al.. (2000). T Cell Reactivity to Heat Shock Protein 60 in Diabetes-Susceptible and Genetically Protected Nonobese Diabetic Mice Is Associated with a Protective Cytokine Profile. The Journal of Immunology. 165(10). 5544–5551. 9 indexed citations

20.

Kast, W. Martin, Claire J. P. Boog, Bart O. Roep, Arie C. Voordouw, & C J Melief. (1988). Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.. The Journal of Immunology. 140(9). 3186–3193. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact